XML 15 R5.htm IDEA: XBRL DOCUMENT v3.4.0.3
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net income $ 4,571 $ 6,418
Adjustments to reconcile net income to net cash provided by operating activities:    
Net gain on sale and disposal of assets (187) 0
Loss on early extinguishment of debt 567 0
Depreciation and amortization 3,734 3,322
Amortization of deferred financing costs 221 226
Accretion of discount on convertible subordinated notes 927 827
Provision for losses on accounts receivable 523 424
Stock-based compensation expense 1,297 1,089
Deferred income tax expense 379 1,559
Changes in operating assets and liabilities that provided (required) cash:    
Accounts and preneed receivables (479) 56
Inventories and other current assets (727) 3,224
Deferred charges and other 230 111
Preneed funeral and cemetery trust investments 7,560 (760)
Accounts payable (1,755) (9)
Accrued and other liabilities (147) (5,020)
Deferred preneed funeral and cemetery revenue (568) (82)
Deferred preneed funeral and cemetery receipts held in trust (6,404) 1,237
Net cash provided by operating activities 9,742 12,622
Cash flows from investing activities:    
Acquisitions and land for new construction (2,685) (4,250)
Purchase of land and buildings previously leased 0 (600)
Net proceeds from the sale of assets 555 0
Capital expenditures (3,595) (5,798)
Net cash used in investing activities (5,725) (10,648)
Cash flows from financing activities:    
Borrowings on the revolving credit facility 11,500 10,600
Payments against the revolving credit facility (50,100) (10,100)
Borrowings on the term loan 39,063 0
Payments against the term loan (2,813) (2,344)
Payments on other long-term debt and obligations under capital leases (321) (370)
Proceeds from the exercise of stock options and employee stock purchase plan contributions 228 212
Dividends on common stock (415) (463)
Payment of loan origination costs related to the credit facility (717) (13)
Excess tax benefit (deficiency) of equity compensation (106) 408
Net cash used in financing activities (3,681) (2,070)
Net increase (decrease) in cash and cash equivalents 336 (96)
Cash and cash equivalents at beginning of period 535 $ 535
Cash and cash equivalents at end of period $ 871